Search

everythinglearnresearchcommunity

for

Search:↓

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

The role of γδT-cells in causing alopecia areata remains unclear.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

PCFCL may have unrecognized subtypes and needs more research.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

CD133+ cells help heal diabetic ulcers by promoting blood vessel growth and activating Wnt signaling.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

The LTF gene may help predict and manage nonspecific orbital inflammation.

ILC1-like cells may contribute to hair loss in alopecia areata.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

FGF21 can help reduce skin inflammation caused by C. acnes.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Different γδ T cell types have unique roles in causing alopecia areata.

Recognizing diverse presentations of folliculotropic mycosis fungoides is crucial to avoid diagnostic errors.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Certain immune cells help hair growth by regulating iron in the skin.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.